SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. on September 4, 2018. The registrant is incorporated in California and identifies as an emerging growth company. The filing serves as a Regulation FD disclosure regarding investor presentation materials intended for use at the Annual B. Riley FBR Healthcare Conference on September 4, 2018, and the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report disclosing the availability of presentation materials rather than a financial statement filing.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The document solely references the attachment of presentation materials (Exhibit 99.1) and the scheduling of conference webcasts.
Guidance, Outlook, and Risks
Management commentary and outlook are contained within the attached Exhibit 99.1 (Investor Presentation), which is incorporated by reference. The filing explicitly disclaims any obligation to update the presentation materials or reflect events occurring after the report date. The presentation was webcast live and archived for 30 days on the company's website. The information in this Item 7.01 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 for specific financial guidance and operational updates.
- Confirm the webcast archive availability on the company's Investor Relations website.
- Note that the presentation materials speak only as of September 4, 2018, with no guarantee of future updates.
- Recognize that this filing does not constitute a formal filing of the presentation data under Section 18 of the Exchange Act.